Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farida Benhadou

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|October 30, 2016
Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional studyInge E Deckers, Farida Benhadou, Marjolein J Koldijk, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening QuestionnaireFadwa El Aissoug, Wassila Bouazza, Hassane Njimi, et al.
Dermatology (Basel, Switzerland)|April 15, 2024
Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015Stephanie Heudens, Anne-Sophie Sarkis, Mathieu Daoud, et al.
Dermatology (Basel, Switzerland)|July 25, 2023
Treatment of Acne with Isotretinoin Should Be Avoided in Patients with Hidradenitis Suppurativa "Conglobata Phenotype"Mathieu Daoud, Mariano Suppa, Stephanie Heudens, et al.
Archives of Dermatological Research|January 8, 2025
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be)Mathieu Daoud, Farida Benhadou, Mariano Suppa, et al.
Dermatology (Basel, Switzerland)|October 13, 2024
Factors Associated with Severe Hidradenitis Suppurativa, Using Hurley Staging and MetascoreMathieu Daoud, Mariano Suppa, Farida Benhadou, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa CohortKelsey R van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|October 30, 2016
Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional studyInge E Deckers, Farida Benhadou, Marjolein J Koldijk, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Prevalence of Hidradenitis Suppurativa in Brussels, Belgium: Validation of a Screening QuestionnaireFadwa El Aissoug, Wassila Bouazza, Hassane Njimi, et al.
Dermatology (Basel, Switzerland)|April 15, 2024
Belgian Patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be): Data, Scores, and Phenotypes since 2015Stephanie Heudens, Anne-Sophie Sarkis, Mathieu Daoud, et al.
Dermatology (Basel, Switzerland)|July 25, 2023
Treatment of Acne with Isotretinoin Should Be Avoided in Patients with Hidradenitis Suppurativa "Conglobata Phenotype"Mathieu Daoud, Mariano Suppa, Stephanie Heudens, et al.
Archives of Dermatological Research|January 8, 2025
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be)Mathieu Daoud, Farida Benhadou, Mariano Suppa, et al.
Dermatology (Basel, Switzerland)|October 13, 2024
Factors Associated with Severe Hidradenitis Suppurativa, Using Hurley Staging and MetascoreMathieu Daoud, Mariano Suppa, Farida Benhadou, et al.
Dermatology (Basel, Switzerland)|February 14, 2024
The Global Hidradenitis Suppurativa Atlas Methodology: Combining Global Proportions in a Pooled AnalysisDorra Bouazzi, Rune K Andersen, Gabrielle R Vinding, et al.
Journal of the American Academy of Dermatology|January 23, 2021
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort studyKelsey R van Straalen, Thrasyvoulos Tzellos, Phillipe Guillem, et al.
Dermatology (Basel, Switzerland)|January 11, 2023
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa CohortKelsey R van Straalen, Thrasyvoulos Tzellos, Afsaneh Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 13, 2025
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologicsGeorgios Nikolakis, Erkan Alpsoy, Monika Arenbergerova, et al.
Pageof 4